Press "Enter" to skip to content

Initial studies show two doses of the Pfizer vaccine may not give enough protection against the variant, but three doses are able to neutralize it, the company says

Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the companies said in a news release on Wednesday.

Preliminary lab studies show two doses of the Pfizer/BioNTech vaccine may not provide sufficient protection against the Omicron coronavirus variant, but three doses are able to neutralize it, the companies said in a news release on Wednesday.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *